17651117	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ JAM-C @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , CD42b , or junctional adhesion molecule C ( @GENETgt$ JAM-C @/GENETgt$ ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17 17 17 25 25 25 17 27 25|26 25 25|26 27 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T6	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ CD42b @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , @GENETgt$ CD42b @/GENETgt$ , or junctional adhesion molecule C ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17|18 17 17|18 17 17 26 26 26 17 28 26 28 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ junctional adhesion molecule C @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , CD42b , or @GENETgt$ junctional adhesion molecule C @/GENETgt$ ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17 17 17 17|21|22 17|21|22 17|21|22 17|21|22 17|22 17|21|22 28 22 28 34 26|34 26|34 34 26|34 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T5	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ CD62P @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to @GENETgt$ CD62P @/GENETgt$ , CD42b , or junctional adhesion molecule C ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 16|15 15 16|15 17 17 17 17 26 26 26 17 28 26 28 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
16324695	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	21 4 4 1 9 9 9 9 14 11 9 11 14 4|13|14 4|13|14 4|13|14 4|14 4|13|14 19 14 19 21 26 26 23 23 21 29 29 26 26 21 21 38 38 38 32|38 38 32|38 32 21	None-BC7
16324695	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	20 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16 18 20 25 25 22 22 20 29 26|29 29 26|29 25 25 20 20 38 32|38 38 32|38 38 38 32 20	None-BC7
16324695	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 7 7 7|6|15 7|6|15 7|6|15 7|15 7|6|15 12 7 12 15 11|4|15 11|4|15 11|4|15 4|15 11|4|15 20 15 20 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	Positive_Correlation
16324695	CHEMICAL	GENE	T11	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 17 11 9|10 9 9|10 11 17 17 17 4 19 17 19 21 26 26 23 23 21 30 26|30 30 26|30 26 26 21 21 38 38 38 38 33 21	None-BC7
16324695	CHEMICAL	GENE	T7	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of fenoterol decreased @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ maximal relaxation ( E(max ) ) of methacholine-contracted preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	24 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13 24 24|28 28 24|28 28 24 30 28 30 30 35 35 28 40 40 39 40 24 24 24 42 46 46 43|44 43 43|44 24	Positive_Correlation
16324695	CHEMICAL	GENE	T6	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17 25 25 17 25 26 30 30 26 30 30 35 35 43 37 35 37 37 37 37 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 9 9 9 9 15 11 9|10 9 9|10 11 15 4|13|15 4|13|15 4|13|15 4|15 4|13|15 20 15 20 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	Positive_Correlation
16324695	CHEMICAL	GENE	T12	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] To investigate the capacity of activated @GENETgt$ PKC @/GENETgt$ to regulate homologous desensitization , we incubated the smooth muscle strips with the combination of both 1 microM PMA and 1 microM @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ .	2 2 4 2 7 7 4|6 4 4|6 10 4 12 10 15 15 2 19 19 19 15 22 22 19 27 27 26 27 22 27 30 31 27|29 27 27|29 15	None-BC7
16324695	CHEMICAL	GENE	T1	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ @CHEMICALSrc$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide @/CHEMICALSrc$ ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	16 16 7 7 4|7 7 4|7 16|5|7 16|5|7 16|5|7 16|7 16|5|7 13 13 7 13 16 16 18 16 18 18 20 23 18 26 26 18 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 16 16	Negative_Correlation
16324695	CHEMICAL	GENE	T2	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ decreased isoprenaline-induced maximal relaxation ( E(max ) ) of methacholine-contracted preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	25 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13|22 13 13|22 25 28 28 25 30 28 30 30 35 35 28 40 40 39 40 25 25 25 42 46 46 43|44 43 43|44 25	None-BC7
16324695	CHEMICAL	GENE	T11	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	20 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16 18 20 25 25 22 22 20 29 26|29 29 26|29 25 25 20 20 38 38 38 34|38 38 34|38 32 20	Positive_Correlation
16324695	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17|20 17 17|20 26 26 17 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ GF 109203X @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( @CHEMICALSrc$ GF 109203X @/CHEMICALSrc$ ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	16 16 9 9 9|4 9 9|4 9 9 16 11 9|11 9|11 9|11 9|11 11 16 16 18 16 18 18 20 23 18 26 26 18 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 16 16	Negative_Correlation
16324695	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 14 11 9 11 14 4|13|14 4|13|14 4|13|14 4|14 4|13|14 19 14 19 21 26 26 23 23 21 29 29 26 26 21 21 38 38|30 38 38|30 38 38 32 21	Positive_Correlation
16324695	CHEMICAL	GENE	T10	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 7 7 17|6|7 17|6|7 17|6|7 17|7 17|6|7 12 7 12 17 17 17 4 19 17|15 17 17|15 19 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	Positive_Correlation
16324695	CHEMICAL	GENE	T5	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of @CHEMICALSrc$ PMA @/CHEMICALSrc$ and fenoterol were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17 25 25 17 25 26 30 30 26 30 30 35 35 43 37 35 35 35 37 37 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T10	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 9 9 9 9 17 11 9|10 9 9|10 11 17 17 17 4 19 17 17 17 19 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	Positive_Correlation
16324695	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ methacholine @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of fenoterol decreased isoprenaline-induced maximal relaxation ( E(max ) ) of @CHEMICALSrc$ methacholine-contracted @/CHEMICALSrc$ preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	24 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13 24 27 27 24 29 27 29 29 35 32|35 35 32|35 27 40 40 39 40 24 24 24 42 46 46 43|44 43 43|44 24	None-BC7
16324695	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16|17 16 16|17 18 21 26 26 23 23 21 29 29 26 26 21 21 38 32|38 38 32|38 38 38 32 21	Positive_Correlation
16324695	CHEMICAL	GENE	T11	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 7 7 17|6|7 17|6|7 17|6|7 17|7 17|6|7 12 7 12 17 17 17 4 19 17 19 21 26 26 23 23 21 30 24|30 30 24|30 26 26 21 21 38 38 38 38 33 21	None-BC7
16324695	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	21 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16|17 16 16|17 18 21 26 26 23 23 21 29 29 26 26 21 21 38 38 38 34|38 38 34|38 32 21	None-BC7
12901032	CHEMICAL	GENE	T8	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ 200 mg/day or rofecoxib 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 28|29 29 28|29 33 30 30 30 37 29 40 40 29 29	Negative_Correlation
12901032	CHEMICAL	GENE	T14	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ warfarin @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on @CHEMICALSrc$ warfarin @/CHEMICALSrc$ therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 6 3|6 6 3|6 2 2 9 2 17 17 13 17|11 17 17|11 17 17 9 22 22 22 20 1 22 22 24 24 24 22 30 30 30 33 31 31 31 37 30 40 40 30 30	None-BC7
12901032	CHEMICAL	GENE	T6	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ salsalate @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , @CHEMICALSrc$ salsalate @/CHEMICALSrc$ , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 21 21 23 23 23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	Negative_Correlation
12901032	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 29 32 30 30 32|30 30 32|30 37 29 40 40 29 29	Negative_Correlation
12901032	CHEMICAL	GENE	T1	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Adverse drug reactions were similar for each @GENETgt$ COX-2 @/GENETgt$ inhibitor , but the rate of edema requiring medical intervention was higher in the @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ group .	3 3 5 5 5 10 10 10|7 10 10|7 5 5 5 14 17 16 14 5 19 17 21 5 26 26 26|22 26 26|22 21 5	None-BC7
12901032	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 24|23 23 24|23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	Negative_Correlation
12901032	CHEMICAL	GENE	T14	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ warfarin @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on @CHEMICALSrc$ warfarin @/CHEMICALSrc$ therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 6 3|6 6 3|6 2 2 9 2 17 9|17 17 9|17 14 17 17 17 9 22 22 22 20 1 22 22 24 24 24 22 30 30 30 33 31 31 31 37 30 40 40 30 30	None-BC7
12901032	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 29 32 30 30 32|30 30 32|30 37 29 40 40 29 29	Negative_Correlation
12901032	CHEMICAL	GENE	T6	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ salsalate @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , @CHEMICALSrc$ salsalate @/CHEMICALSrc$ , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 21 21 23 23 23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	Negative_Correlation
12901032	CHEMICAL	GENE	T7	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 24|23 23 24|23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	Negative_Correlation
12901032	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ 200 mg/day or rofecoxib 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 28|29 29 28|29 33 30 30 30 37 29 40 40 29 29	Negative_Correlation
19372559	CHEMICAL	GENE	T5	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , @GENETgt$ PDIA3 @/GENETgt$ ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13|29 13 13|29 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ high-mobility group protein B2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( @GENETgt$ high-mobility group protein B2 @/GENETgt$ , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 10 8|9|10 8|9|10 8|9|10 8|9|10 8|10 8|9|10 10 10 10 20|13 20 20|13 10 20 10 10 29 29 29 29 29 10 29 10 10 10 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , @GENETgt$ HMGB2 @/GENETgt$ ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13|14 13 13|14 13 19 13 19 13 13 29 29|22 29 29|22 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Our results dissect the roles of @GENETgt$ HMGB1-associated @/GENETgt$ proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 9 9|6 9 9|6 5 13 13 13 5 3 18 15 15 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T6	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Using the cell proliferation assay , we found that knockdown of @GENETgt$ HMGB1-associated @/GENETgt$ proteins resulted in 8-fold to 50-fold decreased chemosensitivity of A549 cells to @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ .	8 5 5 5 1 8 8 8 15 15 14 11|14 14 11|14 10 8 21 19 19 20 21 15 24 24 21 26 24|21 21 24|21 8	None-BC7
19372559	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; @GENETgt$ protein @/GENETgt$ @CHEMICALSrc$ disulfide isomerase family A member 3 @/CHEMICALSrc$ , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 24|21 24 24|21 24|13|22 24|13|22 24|13|22 24|13|22 24|13|22 24|13|22 24|13 24|13|22 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and @GENETgt$ HMGB2 @/GENETgt$ facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 18 14 14|15 14 14|15 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ High-mobility group protein 1 @/GENETgt$ ? [SEP] @GENETgt$ High-mobility group protein 1 @/GENETgt$ ( HMGB1 ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with HMGB1 in the context of DNA damage response .	0|1|13 0|1|13 0|1|13 0|1|13 1|13 0|1|13 7 1 7 13 13 13 13 32 13 17 17 14 20 20 17|15 17 17|15 23 17 13 26 13 26 26 26 32 32 32 34 32 37 37 32 41 41 41 37 32	None-BC7
19372559	CHEMICAL	GENE	T4	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of @GENETgt$ HMGB1 @/GENETgt$ and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3|4 3 3|4 5 9 5 14 14 14 14 9 14 14 14 16|20 20 16|20 14 20 14 14 29 29 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ gamma-H2AX @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no @GENETgt$ gamma-H2AX @/GENETgt$ accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 34 34 31 39 37 36|39 39 36|39 30 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T4	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ GAPDH @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , @GENETgt$ GAPDH @/GENETgt$ ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 19|13 13 19|13 13 29 29 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , @GENETgt$ PDIA3 @/GENETgt$ ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13|29 13 13|29 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ H2AX @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for @GENETgt$ H2AX @/GENETgt$ phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 35 32|35 35 32|35 31 39 38 39 30 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T5	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13 13 5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 34|5 32|34|5 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] High-mobility group protein 1 ( HMGB1 ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with @GENETgt$ HMGB1 @/GENETgt$ in the context of DNA damage response .	3 3 12 3 6 3 6 12 12 12 12 31 12 16 16 13 19 19 16|18 16 16|18 22 16 12 25 12 25 25 25 31 31 31 33 31 31 31 37 37 31 41 41 41 37 31	None-BC7
19372559	CHEMICAL	GENE	T4	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , @GENETgt$ HMGB2 @/GENETgt$ ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13|14 13 13|14 13 16|20 20 16|20 13 20 13 13 29 29 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] High-mobility group protein 1 ( @GENETgt$ HMGB1 @/GENETgt$ ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with HMGB1 in the context of DNA damage response .	3 3 13 3 6 3|5 3 3|5 6 13 13 13 13 32 13 17 17 14 20 20 17|18 17 17|18 23 17 13 26 13 26 26 26 32 32 32 34 32 37 37 32 41 41 41 37 32	None-BC7
19372559	CHEMICAL	GENE	T5	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of @GENETgt$ HMGB1 @/GENETgt$ and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3|4 3 3|4 5 9 5 14 14 14 14 9 14 14 14 19 14 19 14 14 29 29|22 29 29|22 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of HMGB1 and @GENETgt$ HMGB1-associated @/GENETgt$ proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 9|6 9 9|6 5 14 14 14 14 9 14 14 14 19 14 19 14 14 29 29|22 29 29|22 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ GAPDH @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , @GENETgt$ GAPDH @/GENETgt$ ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 19|13 13 19|13 13 29 29|22 29 29|22 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HSPA8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , @GENETgt$ HSPA8 @/GENETgt$ ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13 13 5 35 38 38 38 5 38 5 5|39 5 5|39 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : @GENETgt$ HMGB1 @/GENETgt$ and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 18|13 18 18|13 14 14 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T2	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ p53 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate @GENETgt$ p53 @/GENETgt$ phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 17|20 20 17|20 17 22 17 25 25 22 17 17 31 31 31 17 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	Positive_Correlation
19372559	CHEMICAL	GENE	T2	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in @GENETgt$ PDIA3 @/GENETgt$ knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 34 34 31 38 37 38 30 43 42 42 43 38 45 43 48 48 45 50 48|49 48 48|49 56 56|51 56 56|51 56 48 38 3	None-BC7
19372559	CHEMICAL	GENE	T4	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|23 13|21|23 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of HMGB1 and @GENETgt$ HMGB1-associated @/GENETgt$ proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 9|6 9 9|6 5 14 14 14 14 9 14 14 14 16|20 20 16|20 14 20 14 14 29 29 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13 13 5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 34|5 32|34|5 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and @GENETgt$ PDIA3 @/GENETgt$ has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 26|31 31 26|31 31 31 17 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T4	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HSPA8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , @GENETgt$ HSPA8 @/GENETgt$ ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13 13 5 35 38 38 38 5 38 5 5|39 5 5|39 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ high-mobility group protein B2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( @GENETgt$ high-mobility group protein B2 @/GENETgt$ , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 10 8|9|10 8|9|10 8|9|10 8|9|10 8|10 8|9|10 10 10 10 19 10 19 10 10 29 19|29 29 19|29 29 29 29 10 29 10 10 10 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ glyceraldehyde-3-phosphate dehydrogenase @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @GENETgt$ glyceraldehyde-3-phosphate dehydrogenase @/GENETgt$ , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|17|13 16|17|13 17|13 16|17|13 17 13 13 29 29|21 29 29|21 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
10727715	CHEMICAL	GENE	T8	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T21	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 26 26 21 11 9 9 9|29 9 9|29 37 37 32|37 32|37 37 32|37 30 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	Negative_Correlation
10727715	CHEMICAL	GENE	T10	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T11	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T21	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 27|23 27|23 27 27|23 21 11 9 9 9|28 9 9|28 37 37 37 37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T3	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T9	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T8	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T30	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute fluoxetine-induced changes in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ : the mechanism of action of (+/-)pindolol .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 17 17 15 13 20 20 17|13 13 17|13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T11	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T22	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 27|23 27|23 27 27|23 21 11 9 9 9 36 36 36 36 31 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T29	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 15 13 10|11 11 10|11 15 17 15 20 20 17 23 23 26 23 23 15 31 31 28 28 26 31 31 26 15 15 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 15	None-BC7
10727715	CHEMICAL	GENE	T17	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 19 19 19 19 14 19 11 11 25 25 27 27 22 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T16	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] This effect has been attributed to the antagonist effects of @CHEMICALSrc$ pindolol @/CHEMICALSrc$ at the @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 5 5 5 5 9 9 9 5 11 9|10 9 9|10 18 18 18|13 18|13 18 18|13 9 5	Negative_Correlation
10727715	CHEMICAL	GENE	T17	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 19 19 19 19 14 19 11 11 25 25 28|23 28|23 28 28|23 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T21	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11 25 25 27 27 22 11 9 9 9|28 9 9|28 37 37 37 37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T30	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute fluoxetine-induced changes in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ : the mechanism of action of (+/-)pindolol .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 17 17 15 13 20 20 16|13 13 16|13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T22	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11 25 25 27 27 22 11 9 9 9 36 36 36 36 31 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T14	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 44 44 44 44 39 46 24 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	None-BC7
10727715	CHEMICAL	GENE	T32	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ changes in extracellular 5-HT : the mechanism of action of (+/-)pindolol .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 18 18 12|15 15 12|15 13 21 21 13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T9	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T31	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT : the mechanism of action of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 17 17 15 13 20 20 13 2 23 2 25 23 27 24|25 25 24|25 2	None-BC7
10727715	CHEMICAL	GENE	T13	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T14	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 45 45 40|45 40|45 45 40|45 39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T6	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T14	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T5	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T18	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 19 19 19 19 13 19 11 11 25 25 27 27 22 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T2	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T18	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 19 19 19 19 13 19 11 11 25 25 28|23 28|23 28 28|23 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T31	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute fluoxetine-induced changes in extracellular 5-HT : the mechanism of action of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 17 17 15 13 20 20 13 2 23 2 25 23 27 25|23 25 25|23 2	None-BC7
10727715	CHEMICAL	GENE	T22	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 26 26 21 11 9 9 9 36 36 32|36 32|36 36 32|36 30 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T9	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T18	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 20 20 20|15 20|15 20 20|15 13 20 11 11 26 26 28 28 23 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	Negative_Correlation
10727715	CHEMICAL	GENE	T13	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 44 44 44 44 39 46 24 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	None-BC7
10727715	CHEMICAL	GENE	T7	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T13	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 45 45 40|45 40|45 45 40|45 39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T19	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11|19 11 11|19 26 26 28 28 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T19	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11|20 11 11|20 25 25 27 27 21 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T6	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T5	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T17	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 20 20 20|15 20|15 20 20|15 14 20 11 11 26 26 28 28 23 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	Negative_Correlation
10727715	CHEMICAL	GENE	T1	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 16 16 23 23 26 23 23 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T19	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11|20 11 11|20 25 25 28|23 28|23 28 28|23 21 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T2	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T12	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T12	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	Negative_Correlation
10727715	CHEMICAL	GENE	T4	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T3	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T11	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T32	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ changes in extracellular 5-HT : the mechanism of action of (+/-)pindolol .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 18 18 13|15 15 13|15 13 21 21 13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T10	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T29	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 15 13 10|11 11 10|11 15 17 15 20 20 17 23 23 26 23 23 15 31 31 28 28 26 31 31 26 15 15 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 15	None-BC7
10727715	CHEMICAL	GENE	T12	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T10	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T4	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T7	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T1	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 16 16 23 23 26 23 23 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
9890894	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] Previously , we reported that a primary heparin or heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ binding site resides in a distinct sequence in immunoglobulin (Ig)-like module II of the three modules of @GENETgt$ FGFR @/GENETgt$ .	4 4 4 4 15 8 8 15 8 14 10|14 14 10|14 14 8 4 19 19 19 15 21 19 23 21 23 28 28 28 21 30 28 28 28 4	Association
9890894	CHEMICAL	GENE	T1	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ transmembrane receptor kinase @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of FGF , the @GENETgt$ transmembrane receptor kinase @/GENETgt$ ( FGFR ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 7 9 12 9|11|12 9|11|12 9|11|12 9|12 9|11|12 17 12 17 9 7 22 18|7 7 18|7 24 26 24 26 27 28 28 32 28 24	None-BC7
9890894	CHEMICAL	GENE	T3	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGFR1IIIc @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length @GENETgt$ FGFR1IIIc @/GENETgt$ , an isoform that otherwise absolutely rejects FGF-7 , resulted in gain of FGF-7 binding .	3 3 21 6 6 3|5 3 3|5 10 10 8|6 6 8|6 10 14 10 18 18 18 14 18 21 21 23 21 26 26 23 21	Association
9890894	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length FGFR1IIIc , an isoform that otherwise absolutely rejects FGF-7 , resulted in gain of @GENETgt$ FGF-7 @/GENETgt$ binding .	3 3 20 6 6 3|5 3 3|5 10 10 6 10 13 10 17 17 17 13 17 20 20 22 20 26 26|22 26 26|22 22 20	None-BC7
9890894	CHEMICAL	GENE	T2	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Addition of a specific number of FGFR sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module II resulted in a gain in affinity for @GENETgt$ FGF-7 @/GENETgt$ .	17 5 5 5 1 8 8 5 11 11 1|10 1 1|10 15 15 11 15 17 20 20 17 22 20 24 22 22 22 17	None-BC7
9890894	CHEMICAL	GENE	T2	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module II @/GENETgt$ ? [SEP] Addition of a specific number of FGFR sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of @GENETgt$ Ig module II @/GENETgt$ resulted in a gain in affinity for FGF-7 .	18 5 5 5 1 8 8 5 11 11 1|10 1 1|10 14 11|12|14 11|12|14 11|12|14 11|14 11|12|14 18 21 21 18 23 21 25 23 18	Association
9890894	CHEMICAL	GENE	T3	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length FGFR1IIIc , an isoform that otherwise absolutely rejects @GENETgt$ FGF-7 @/GENETgt$ , resulted in gain of FGF-7 binding .	3 3 21 6 6 3|5 3 3|5 10 10 6 10 13 10 17 17 17 13 16|17 17 16|17 21 21 23 21 26 26 23 21	None-BC7
9890894	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGF @/GENETgt$ ? [SEP] These results suggest that a complex of Ig module II and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the FGFR ectodomain and that flanking structural domains modify @GENETgt$ FGF @/GENETgt$ affinity and determine specificity .	2 3 3 17 6 17 9 9 6 9 9 13 9|12 9 9|12 17 17 3 20 20 17 24 24 24 20 17 30 29 29 30 17 33|29 33 33|29 30 30 30 35 3	None-BC7
9890894	CHEMICAL	GENE	T6	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-2 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , @GENETgt$ FGF-2 @/GENETgt$ , and FGF-7 .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 18 18 18 18 18 18 18 13	None-BC7
9890894	CHEMICAL	GENE	T4	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ Ig module II @/GENETgt$ ? [SEP] These results suggest that a complex of @GENETgt$ Ig module II @/GENETgt$ and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the FGFR ectodomain and that flanking structural domains modify FGF affinity and determine specificity .	2 3 3 18 6 18 8 8|6|7 8|6|7 8|6|7 8|6 8|6|7 8 14 8|10 8 8|10 18 18 3 21 21 18 25 25 25 21 18 31 30 30 31 18 33 31 31 31 35 3	Association
9890894	CHEMICAL	GENE	T6	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module I @/GENETgt$ ? [SEP] @GENETgt$ Ig module I @/GENETgt$ and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , FGF-2 , and FGF-7 .	0|1|14 0|1|14 0|1|14 1|14 0|1|14 1 7 1|3 1 1|3 11 11 7 11 14 14 17 17 14 19 17 19 19 19 19 19 14	None-BC7
9890894	CHEMICAL	GENE	T5	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ immunoglobulin (Ig)-like module II @/GENETgt$ ? [SEP] Previously , we reported that a primary heparin or heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ binding site resides in a distinct sequence in @GENETgt$ immunoglobulin (Ig)-like module II @/GENETgt$ of the three modules of FGFR .	4 4 4 4 15 8 8 15 8 14 10|14 14 10|14 14 8 4 19 19 19 15 21 19|21 19|21 19|21 19|21 19|21 19|21 29 29 29 21 31 29 4	Association
9890894	CHEMICAL	GENE	T4	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR ectodomain @/GENETgt$ ? [SEP] These results suggest that a complex of Ig module II and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the @GENETgt$ FGFR ectodomain @/GENETgt$ and that flanking structural domains modify FGF affinity and determine specificity .	2 3 3 17 6 17 9 9 6 9 9 13 9|12 9 9|12 17 17 3 20 20 17 23 23 20|21|23 20|21|23 20|23 20|21|23 17 31 30 30 31 17 33 31 31 31 35 3	None-BC7
9890894	CHEMICAL	GENE	T1	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of FGF , the transmembrane receptor kinase ( @GENETgt$ FGFR @/GENETgt$ ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 7 9 14 14 14 9 16 14|15 14 14|15 16 9 7 22 20|7 7 20|7 24 26 24 26 27 28 28 32 28 24	None-BC7
9890894	CHEMICAL	GENE	T6	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , FGF-2 , and @GENETgt$ FGF-7 @/GENETgt$ .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 18 18 18 18 18|21 18 18|21 13	None-BC7
9890894	CHEMICAL	GENE	T6	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module III @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of @GENETgt$ Ig module III @/GENETgt$ are dispensable for high-affinity binding of FGF-1 , FGF-2 , and FGF-7 .	2 14 2 2 6 2|5 2 2|5 9 9|6|7 9|6|7 9|6|7 9|6 9|6|7 14 14 17 17 14 19 17 19 19 19 19 19 14	Association
9890894	CHEMICAL	GENE	T2	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] Addition of a specific number of @GENETgt$ FGFR @/GENETgt$ sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module II resulted in a gain in affinity for FGF-7 .	18 5 5 5 1 9 9|6 9 9|6 5 12 12 1|10 1 1|10 16 16 12 16 18 21 21 18 23 21 25 23 18	None-BC7
9890894	CHEMICAL	GENE	T6	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-1 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of @GENETgt$ FGF-1 @/GENETgt$ , FGF-2 , and FGF-7 .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 16 16 18 18 18 18 18 13	None-BC7
9890894	CHEMICAL	GENE	T1	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGF @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of @GENETgt$ FGF @/GENETgt$ , the transmembrane receptor kinase ( FGFR ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 8|7 7 8|7 9 15 15 15 9 17 15 17 9 7 22 20|7 7 20|7 24 26 24 26 27 28 28 32 28 24	None-BC7
23298863	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] The IC50 values for @GENETgt$ Gli1 @/GENETgt$ mRNA inhibition in the tumor and skin by @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ were estimated to be 0.0457 and 0.113 g/ml , respectively .	3 3 18 8 8|4 8 8|4 8 3 11 11 8 11 11 15 8|13 8 8|13 18 18 21 21 18 21 21 21 21 21 18	Negative_Correlation
23298863	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and the responses of Gli1 mRNA in tumor-associated stromal or skin cells and the antitumor effect of @GENETgt$ hedgehog @/GENETgt$ inhibition .	2 8 5 5 2 8 8 8 10 8 12 10 15 15 12 18 18 15 20 18|19 18 18|19 18 24 18 27 27 24 33 33 33 30 30 24 18 37 37 18 41 41|37 41 41|37 37 8	None-BC7
23298863	CHEMICAL	GENE	T4	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and the responses of @GENETgt$ Gli1 @/GENETgt$ mRNA in tumor-associated stromal or skin cells and the antitumor effect of hedgehog inhibition .	2 8 5 5 2 8 8 8 10 8 12 10 15 15 12 18 18 15 20 18|19 18 18|19 18 24 18 28 24|28 28 24|28 24 34 34 34 31 31 24 18 38 38 18 41 41 38 8	None-BC7
23298863	CHEMICAL	GENE	T5	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] To this end , we built pharmacokinetic and pharmacodynamic models that describe the relationship of the concentrations of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ plasma to the responses of @GENETgt$ Gli1 @/GENETgt$ mRNA in the tumor ( target ) and skin ( surrogate ) and to tumor growth inhibition in mice bearing xenografts of human pancreatic tumors ( PAN-04 ) .	3 3 6 6 6 6 10 7 7 6 12 10 14 12 17 17 14 21 18|21 21 18|21 17 24 24 14 28 24|28 28 24|28 24 31 31 24 33 31 33 31 31 38 36 38 24 44 44 44 24 46 44 46 47 52 52 52 48 54 44 54 6	None-BC7
23298863	CHEMICAL	GENE	T1	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ and @GENETgt$ Smo @/GENETgt$ ? [SEP] @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ ( TAK-441 ) is a potent , selective hedgehog signaling pathway inhibitor that binds to @GENETgt$ Smo @/GENETgt$ and is being developed for the treatment of cancer .	0|14 14 0|14 4 1 4 14 14 14 8 8 14 14 14 14 16 14 18 16 16 16 16 23 23 16 26 26 23 28 26 14	None-BC7
23298863	CHEMICAL	GENE	T6	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] Pharmacokinetic and pharmacodynamic modeling of @GENETgt$ hedgehog @/GENETgt$ inhibitor @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	4 1 1 4 9 9|5 9 9|5 9 4|7 4 4|7 13 13 4 18 18 18 18 13 18 21 18 26 26 26 26 18 4	Negative_Correlation
23298863	CHEMICAL	GENE	T1	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ ( TAK-441 ) is a potent , selective @GENETgt$ hedgehog @/GENETgt$ signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer .	0|15 15 0|15 4 1 4 15 15 15 8 8 9|15 15 9|15 15 15 15 17 15 19 17 17 23 23 17 26 26 23 28 26 15	None-BC7
23298863	CHEMICAL	GENE	T6	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ for the inhibition of @GENETgt$ Gli1 @/GENETgt$ messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	4 1 1 4 8 8 8 4|7 4 4|7 12 12 4 18 18|12 18 18|12 18 18 12 18 21 18 26 26 26 26 18 4	Negative_Correlation
23298863	CHEMICAL	GENE	T3	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Smo @/GENETgt$ ? [SEP] 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide ( @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ ) is a potent , selective hedgehog signaling pathway inhibitor that binds to @GENETgt$ Smo @/GENETgt$ and is being developed for the treatment of cancer .	14 3 1|2 1 1|2 3 14 14 14 8 8 14 14 14 14 16 14 18 16 16 16 16 23 23 16 26 26 23 28 26 14	Association
23298863	CHEMICAL	GENE	T3	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide ( @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ ) is a potent , selective @GENETgt$ hedgehog @/GENETgt$ signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer .	15 3 1|2 1 1|2 3 15 15 15 8 8 9|15 15 9|15 15 15 15 17 15 19 17 17 23 23 17 26 26 23 28 26 15	Negative_Correlation
23142699	CHEMICAL	GENE	T3	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] Proto-oncogene @GENETgt$ PIM-1 @/GENETgt$ is a novel @CHEMICALSrc$ estrogen @/CHEMICALSrc$ receptor target associating with high grade breast tumors .	2 1|10 10 1|10 10 10 10 10|5 10 10|5 10 10 16 16 16 16 16 10 10	None-BC7
23142699	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ ER @/GENETgt$ ? [SEP] We show that the expression of PIM-1 is induced in response to @CHEMICALSrc$ estradiol @/CHEMICALSrc$ in MCF-7 cells and that the induction is mediated by @GENETgt$ ER-regulated @/GENETgt$ enhancers located distally upstream from the gene .	2 2 9 5 9 7 5 9 2 11 9 13 11|12 11 11|12 17 17 11 9 23 21 23 23 9 27 27|23 27 27|23 23 27 30 28 33 33 30 2	Positive_Correlation
23142699	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ Proto-oncogene @/GENETgt$ ? [SEP] @GENETgt$ Proto-oncogene @/GENETgt$ PIM-1 is a novel @CHEMICALSrc$ estrogen @/CHEMICALSrc$ receptor target associating with high grade breast tumors .	0|3 3 0|3 10 10 10 10 10|5 10 10|5 10 10 16 16 16 16 16 10 10	None-BC7
23142699	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] We show that the expression of @GENETgt$ PIM-1 @/GENETgt$ is induced in response to @CHEMICALSrc$ estradiol @/CHEMICALSrc$ in MCF-7 cells and that the induction is mediated by ER-regulated enhancers located distally upstream from the gene .	2 2 10 5 10 7 5|6 5 5|6 10 2 12 10 14 12 12 12 18 18 12 10 24 22 24 24 10 27 27 24 27 30 28 33 33 30 2	Positive_Correlation
23142699	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogens @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] In sum , identification of @GENETgt$ PIM-1 @/GENETgt$ as an ER target gene adds a novel potential mechanism by which @CHEMICALSrc$ estrogens @/CHEMICALSrc$ can contribute to breast cancer cell proliferation and carcinogenesis .	2 13 13 13 6 4|5 4 4|5 12 12 12 12 4 13 17 17 17 13 19 23 18|23 23 18|23 23 17 27 27 27 23 27 28 28 13	None-BC7
23142699	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogens @/CHEMICALSrc$ and @GENETgt$ ER @/GENETgt$ ? [SEP] In sum , identification of PIM-1 as an @GENETgt$ ER @/GENETgt$ target gene adds a novel potential mechanism by which @CHEMICALSrc$ estrogens @/CHEMICALSrc$ can contribute to breast cancer cell proliferation and carcinogenesis .	2 13 13 13 6 4 12 12 8|12 12 8|12 12 4 13 17 17 17 13 19 23 18|23 23 18|23 23 17 27 27 27 23 27 28 28 13	None-BC7
2568748	CHEMICAL	GENE	T1	T4	True	0	What is [Drugprot] between @CHEMICALSrc$ Esmolol @/CHEMICALSrc$ and @GENETgt$ beta 1-adrenergic receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Esmolol @/CHEMICALSrc$ , a unique cardioselective @GENETgt$ beta 1-adrenergic receptor @/GENETgt$ blocker with a half-life of 9 minutes , can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy .	0|20 20 0|20 1 11 11 11 11|5 11|5 11|5 11 11|5 1 14 14 11 17 17 14 1 20 20 22 20 25 25 22 28 28 25 31 31 20 35 35 35 31 20	Negative_Correlation
8142113	CHEMICAL	GENE	T5	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ retinoic acid binding protein @/GENETgt$ ? [SEP] Furthermore , @CHEMICALSrc$ adapalene @/CHEMICALSrc$ does not bind to members of the cellular @GENETgt$ retinoic acid binding protein @/GENETgt$ family .	7 7 2|7 7 2|7 7 7 7 9 7 18 18 18 18|11 18|11 18|11 18|11 18 18|11 9 7	None-BC7
8142113	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ RAR alpha @/GENETgt$ ? [SEP] It has a particular selectivity profile for the known nuclear @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors with low affinity for @GENETgt$ RAR alpha @/GENETgt$ and no transactivating potential for RXR alpha .	2 2 6 6 6 2 14 14 14 14 10|14 10|14 14 10|14 6 17 17 2 19 16|17|19 16|17|19 17|19 16|17|19 17 25 25 17 28 28 25 2	None-BC7
8142113	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ RXR alpha @/GENETgt$ ? [SEP] It has a particular selectivity profile for the known nuclear @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors with low affinity for RAR alpha and no transactivating potential for @GENETgt$ RXR alpha @/GENETgt$ .	2 2 6 6 6 2 14 14 14 14 10|14 10|14 14 10|14 6 17 17 2 20 20 17 17 24 24 17 26 24|26|23 24|26|23 24|26 24|26|23 2	None-BC7
10727528	CHEMICAL	GENE	T3	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible ET-1 binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and ETA receptor antagonists should be used to evaluate the physiopathological role of @GENETgt$ ET-1 @/GENETgt$ and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 13 13 13 7 11 11 13 13 4 13 17 17 14 19 13 13 13 35 22 25 35 27 25|26 25 25|26 27 31 32 27 35 35 13 37 35 40 40 37 42 40 40 40 37 49 49 49 49 37 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T10	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of @GENETgt$ (125)I-ET-1 @/GENETgt$ ETA receptor complexes both in the absence and the presence of unlabeled ET-1 .	0|1|4 0|1|4 1|4 0|1|4 4 4 11 11|4 11 11|4 11 11 5 15 15 15 4 15 18 15 21 21 18 4	Association
10727528	CHEMICAL	GENE	T11	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] Salicylic acid promotes dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ ETA receptor complexes both in the absence and the presence of unlabeled @GENETgt$ ET-1 @/GENETgt$ .	2 3 3 3 10 10|5 10 10|5 10 10 4 14 14 14 3 14 17 14 20 20 17|18 17 17|18 3	None-BC7
10727528	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ endothelin-1 @/GENETgt$ ? [SEP] This study shows that aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ , its major blood metabolite , reverse contractile actions of @GENETgt$ endothelin-1 @/GENETgt$ ( ET-1 ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16 5 5|6|7 5|6|7 5|7 5|6|7 5 14 14 14 5 5 3 18 16 20 17|18 18 17|18 23 20 23 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T4	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] This study shows that @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and sodium salicylate , its major blood metabolite , reverse contractile actions of endothelin-1 ( @GENETgt$ ET-1 @/GENETgt$ ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16|4 16 16|4 5 9 5 5 14 14 14 5 5 3 18 16 20 18 22 20 20 20 22 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T9	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ rat ETA receptors @/GENETgt$ ? [SEP] Salicylates inhibit @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ binding to recombinant @GENETgt$ rat ETA receptors @/GENETgt$ .	2 2 2|5 5 2|5 2 8 8 8|5|6 8|5|6 8|5|6 8|5 8|5|6 2	None-BC7
10727528	CHEMICAL	GENE	T7	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] Inhibition of the actions of @GENETgt$ ET-1 @/GENETgt$ by @CHEMICALSrc$ salicylates @/CHEMICALSrc$ is apparently competitive .	13 4 4 1 6 4|5 4 4|5 9 4|7 4 4|7 13 13 13 13	Negative_Correlation
10727528	CHEMICAL	GENE	T10	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled @GENETgt$ ET-1 @/GENETgt$ .	0|1|4 0|1|4 1|4 0|1|4 4 4 10 10 10 10 5 14 14 14 4 14 17 14 20 20 17 17 17 4	None-BC7
10727528	CHEMICAL	GENE	T2	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] It is concluded that @CHEMICALSrc$ salicylates @/CHEMICALSrc$ are allosteric inhibitors of @GENETgt$ ETA receptors @/GENETgt$ .	3 3 3 9 9|4 9 9|4 9 9 3 11 9|11 9|11 9|11 9|11 3	None-BC7
10727528	CHEMICAL	GENE	T3	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible @GENETgt$ ET-1 @/GENETgt$ binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and ETA receptor antagonists should be used to evaluate the physiopathological role of ET-1 and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 14 14 14 7 12 9|12 12 9|12 14 14 4 14 18 18 15 20 14 14 14 36 23 26 36 28 26 26 26 28 32 33 28 36 36 14 38 36 41 41 38 43 41 38 49 49 49 49 38 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T8	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ inhibit @GENETgt$ (125)I-ET-1 @/GENETgt$ binding to recombinant rat ETA receptors .	0|3 3 0|3 3 2|6 6 2|6 3 11 11 11 11 6 3	Association
10727528	CHEMICAL	GENE	T6	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Ca(2+) @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] They also prevent the intracellular @CHEMICALSrc$ Ca(2 + ) @/CHEMICALSrc$ mobilizing action of @GENETgt$ ET-1 @/GENETgt$ in cultured endothelial cells but not those of neuromedin B or UTP .	3 3 3 6 6 10|3|5|6 10|3|5|6 10|3|5|6 10|3|6 10|3|5|6 11 6 13 9|11 11 9|11 18 18 18 11 20 18 18 24 24 21 24 24 3	None-BC7
10727528	CHEMICAL	GENE	T10	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of (125)I-ET-1 @GENETgt$ ETA receptor @/GENETgt$ complexes both in the absence and the presence of unlabeled ET-1 .	0|1|4 0|1|4 1|4 0|1|4 4 4 11 11 11|5 11|5 11 11|5 5 15 15 15 4 15 18 15 21 21 18 4	Association
10727528	CHEMICAL	GENE	T14	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETB receptor @/GENETgt$ ? [SEP] Salicylates do not promote dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ @GENETgt$ ETB receptor @/GENETgt$ complexes .	4 4 4 4 4 12 12|6 12 12|6 12|7 12|7 12 12|7 5 4	Association
10727528	CHEMICAL	GENE	T13	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ETB receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ do not promote dissociation of (125)I-ET-1 @GENETgt$ ETB receptor @/GENETgt$ complexes .	0|5 5 0|5 5 5 5 5 12 12 12|7 12|7 12 12|7 6 5	None-BC7
10727528	CHEMICAL	GENE	T18	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] Aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ inhibit endothelin @GENETgt$ ETA receptors @/GENETgt$ by an allosteric type of mechanism .	6 1 1|2|3 1|2|3 1|3 1|2|3 6 8 8|5|6 8|5|6 8|6 8|5|6 14 14 14 6 16 14 6	None-BC7
10727528	CHEMICAL	GENE	T13	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ do not promote dissociation of @GENETgt$ (125)I-ET-1 @/GENETgt$ ETB receptor complexes .	0|5 5 0|5 5 5 5 5 12 12|6 12 12|6 12 12 6 5	None-BC7
10727528	CHEMICAL	GENE	T17	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ Aspirin @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Aspirin @/CHEMICALSrc$ and sodium salicylate inhibit endothelin @GENETgt$ ETA receptors @/GENETgt$ by an allosteric type of mechanism .	0|6 6 0|6 1 5 1 6 8 8|6 8|6 8|6 8|6 14 14 14 6 16 14 6	None-BC7
10727528	CHEMICAL	GENE	T12	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] It has no influence on the rate of association of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ to @GENETgt$ ETA receptors @/GENETgt$ .	2 2 4 2 7 7 4 9 7 11 9|10 9 9|10 14 9|12|14 9|12|14 9|14 9|12|14 2	Association
10727528	CHEMICAL	GENE	T3	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible ET-1 binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ antagonists should be used to evaluate the physiopathological role of ET-1 and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 13 13 13 7 11 11 13 13 4 13 17 17 14 19 13 13 13 36 22 25 36 27 25|26 25 25|26 27 33|28|30 33|28|30 33|30 33|28|30 27 36 36 13 38 36 41 41 38 43 41 38 49 49 49 49 38 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T4	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and @GENETgt$ endothelin-1 @/GENETgt$ ? [SEP] This study shows that @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and sodium salicylate , its major blood metabolite , reverse contractile actions of @GENETgt$ endothelin-1 @/GENETgt$ ( ET-1 ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16|4 16 16|4 5 9 5 5 14 14 14 5 5 3 18 16 20 18 18 18 23 20 23 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T6	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Ca(2+) @/CHEMICALSrc$ and @GENETgt$ neuromedin B @/GENETgt$ ? [SEP] They also prevent the intracellular @CHEMICALSrc$ Ca(2 + ) @/CHEMICALSrc$ mobilizing action of ET-1 in cultured endothelial cells but not those of @GENETgt$ neuromedin B @/GENETgt$ or UTP .	3 3 3 6 6 10|3|5|6 10|3|5|6 10|3|5|6 10|3|6 10|3|5|6 11 6 13 11 17 17 17 11 19 17 17 22 18|20|22 18|20|22 20|22 18|20|22 22 22 3	None-BC7
10727528	CHEMICAL	GENE	T8	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ rat ETA receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ inhibit (125)I-ET-1 binding to recombinant @GENETgt$ rat ETA receptors @/GENETgt$ .	0|3 3 0|3 3 5 3 8 8 8|5|6 8|5|6 8|5|6 8|5 8|5|6 3	Association
10727528	CHEMICAL	GENE	T11	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] Salicylic acid promotes dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ @GENETgt$ ETA receptor @/GENETgt$ complexes both in the absence and the presence of unlabeled ET-1 .	2 3 3 3 11 11|5 11 11|5 11|6 11|6 11 11|6 4 15 15 15 3 15 18 15 21 21 18 3	Association
10727528	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] This study shows that aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ , its major blood metabolite , reverse contractile actions of endothelin-1 ( @GENETgt$ ET-1 @/GENETgt$ ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16 5 5|6|7 5|6|7 5|7 5|6|7 5 14 14 14 5 5 3 18 16 20 18 22 19|20 20 19|20 22 28 28 28 18 28 32 32 28 3	None-BC7
23150495	CHEMICAL	GENE	T1	T5	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Consistent with an adult-onset isolated GHD model , mutant animals are hypoglycemic and display increased @GENETgt$ insulin @/GENETgt$ sensitivity and @CHEMICALSrc$ glucose @/CHEMICALSrc$ clearance .	12 4 4 7 7 7 1 12 10 12 12 12 12 12 12 18|15 18 18|15 12 18 18|22 22 18|22 18 12	None-BC7
16213084	CHEMICAL	GENE	T5	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 22 18|22 22 18|22 22 20|14 14 20|14 22 30 25 30 30 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T7	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 30 24 22|30 30 22|30 30 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 30 24 30 30|23 30 30|23 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T9	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 29 24 29 29 29 22 12 32 28|12 12 28|12 37 37 37 32 3	Association
16213084	CHEMICAL	GENE	T9	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 29 24 29 29 29 21 12 32 12|30 12 12|30 37 37 37 32 3	Association
16213084	CHEMICAL	GENE	T14	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 20|21|22 20|21|22 20|22 20|21|22 4 4 34 29 34 32 32 29 34 26 37 37 34|37 34|37 34|37 34|37 34|37 4	None-BC7
16213084	CHEMICAL	GENE	T9	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 14 21 25 23 24|25|21 24|25|21 24|25|21 24|25|21 25|21 24|25|21 12 32 27|12 12 27|12 37 37 37 32 3	Association
16213084	CHEMICAL	GENE	T12	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21 21|14 21 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 37 37 34|35|37 34|35|37 34|35|37 34|37 34|35|37 4	None-BC7
16213084	CHEMICAL	GENE	T8	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled @/GENETgt$ @CHEMICALSrc$ monocarboxylate transport system @/CHEMICALSrc$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 14 21 27 23 24|27 27 24|27 25|27|21 25|27|21 25|27|21 27|21 25|27|21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T8	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 30 24 30 25|30 30 25|30 30 21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T7	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 30 24 24|30 30 24|30 30 30 21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T18	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40 40|35 40 40|35 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T15	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 23 20 4 4 34 26|29 29 26|29 34 32 32 29 34 25 37 37 34|35|37 34|35|37 34|35|37 34|37 34|35|37 4	Association
16213084	CHEMICAL	GENE	T12	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 22 22 14|22 22 14|22 22 22 17|22 22 17|22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T18	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40 40|34 40 40|34 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T2	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	3 3 17 6 6 3 11 11 8|11 11 8|11 6 14 14 3 17 17 17 17 26 21 26 24 24 21 26 18 28 26 26 26 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T1	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	4 1|4 4 1|4 17 7 7 4 11 11 11 7 14 14 4 17 17 17 17 26 21 26 24 24 21 26 18 28 26 26 26 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T14	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 21|23 21|23 21|23 21|23 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	Negative_Correlation
16213084	CHEMICAL	GENE	T14	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 20|21|23 20|21|23 21|23 20|21|23 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	Negative_Correlation
16213084	CHEMICAL	GENE	T11	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 22 22 22 22 22 16|22 22 16|22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T15	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 35 26|30 30 26|30 35 33 33 30 35 26 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T11	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 22 22 13|22 13|22 22 13|22 22 22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T1	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	4 1|4 4 1|4 17 7 7 4 11 11 11 7 14 14 4 17 17 17 17 26 21 26 24 24 21 26 18 28 26 28 28 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T11	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 21 21 21 21 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 37 37 34|37 34|37 34|37 34|37 34|37 4	None-BC7
16213084	CHEMICAL	GENE	T3	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	3 3 16 6 6 3 10 10 10 6 13 13 3 16 16 16 16 26 18|21 21 18|21 26 24 24 21 26 17 28 26 28 28 28 28 16	Association
16213084	CHEMICAL	GENE	T2	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	3 3 17 6 6 3 11 11 8|11 11 8|11 6 14 14 3 17 17 17 17 26 21 26 24 24 21 26 18 28 26 28 28 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T4	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 23 23 23 17|23 17|23 17|23 23 17|23 15 23 30 25 30 30 30 23 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T15	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 35 25|30 30 25|30 35 33 33 30 35 26 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T4	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 22 22 22 22 22 22 20|15 15 20|15 22 30 25 30 30 30 22 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T5	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity @/GENETgt$ @CHEMICALSrc$ monocarboxylate transporter @/CHEMICALSrc$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 23 23 23 17|23 23 17|23 18|23 18|23 23 18|23 14 23 30 25 30 30 30 23 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T16	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 23 20 4 4 33 28 33 31 31 28 33 25 37 34|37 37 34|37 33|35|37 33|35|37 33|35|37 33|37 33|35|37 4	None-BC7
16213084	CHEMICAL	GENE	T4	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 22 22 22 22 22 22 15 22 26 24 24|26|22 24|26|22 24|26|22 24|26|22 26|22 24|26|22 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T5	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 22 18|22 22 18|22 22 14 22 26 24 24|26|22 24|26|22 24|26|22 24|26|22 26|22 24|26|22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T3	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	3 3 16 6 6 3 10 10 10 6 13 13 3 16 16 16 16 26 18|21 21 18|21 26 24 24 21 26 17 28 26 26 26 28 28 16	Association
16213084	CHEMICAL	GENE	T16	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40|34 40 40|34 40 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T16	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40|33 40 40|33 40 40 34 4	None-BC7
23587425	CHEMICAL	GENE	T3	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ CHK1 @/GENETgt$ ? [SEP] Potency switch between @GENETgt$ CHK1 @/GENETgt$ and MK2 : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based kinase inhibitors .	2 2 4 2|3 2 2|3 4 4 2 2 11 9 9 9 11 16 16 11 2	Negative_Correlation
23587425	CHEMICAL	GENE	T4	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ MK2 @/GENETgt$ ? [SEP] Potency switch between CHK1 and @GENETgt$ MK2 @/GENETgt$ : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ kinase inhibitors .	2 2 4 2 4 4|5 4 4|5 2 2 11 9 11 16|11 16 16|11 16 11 2	Negative_Correlation
23587425	CHEMICAL	GENE	T4	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ kinase @/GENETgt$ ? [SEP] Potency switch between CHK1 and MK2 : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ @GENETgt$ kinase @/GENETgt$ inhibitors .	2 2 4 2 4 4 2 2 10 8 10 16|11 16 16|11 16|12 16 16|12 10 2	Negative_Correlation
23587425	CHEMICAL	GENE	T3	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ MK2 @/GENETgt$ ? [SEP] Potency switch between CHK1 and @GENETgt$ MK2 @/GENETgt$ : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based kinase inhibitors .	2 2 4 2 4 4|5 4 4|5 2 2 11 9 9 9 11 16 16 11 2	Negative_Correlation
23587425	CHEMICAL	GENE	T4	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ CHK1 @/GENETgt$ ? [SEP] Potency switch between @GENETgt$ CHK1 @/GENETgt$ and MK2 : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ kinase inhibitors .	2 2 4 2|3 2 2|3 4 4 2 2 11 9 11 16|11 16 16|11 16 11 2	Negative_Correlation
23587425	CHEMICAL	GENE	T3	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ kinase @/GENETgt$ ? [SEP] Potency switch between CHK1 and MK2 : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based @GENETgt$ kinase @/GENETgt$ inhibitors .	2 2 4 2 4 4 2 2 10 8|9 8 8|9 10 16 16|12 16 16|12 10 2	Negative_Correlation
11792932	CHEMICAL	GENE	T41	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ Testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : @CHEMICALSrc$ Testosterone-to-estradiol @/CHEMICALSrc$ ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , testolactone , and resulting changes in semen parameters .	1 10 2|6 6 2|6 6 10 9 9 6 1 12 10 17 17 17|13 17 17|13 12 17 17 17 10 10 22 26 26 23 10	None-BC7
11792932	CHEMICAL	GENE	T28	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of anastrozole , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratios .	2 2 4 2 6 4 6 13 10 13 10|13 13 10|13 6 6 17 17 4 17 17 17 23 23 20 29 29 29 25|29 29 25|29 4 2	None-BC7
11792932	CHEMICAL	GENE	T16	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : @CHEMICALSrc$ Testosterone-to-estradiol @/CHEMICALSrc$ ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , testolactone , and resulting changes in semen parameters .	1 10 2|6 6 2|6 6 10 9 9 6 1 12 10 17 17 17|13 17 17|13 12 17 17 17 10 10 22 26 26 23 10	None-BC7
11792932	CHEMICAL	GENE	T29	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of anastrozole , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratios .	2 2 4 2 6 4 6 13 10 13 10|13 13 10|13 6 6 17 17 4 17 17 17 23 23 20 29 29 29 25|29 29 25|29 4 2	None-BC7
11792932	CHEMICAL	GENE	T1	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ testolactone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : Testosterone-to-estradiol ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , @CHEMICALSrc$ testolactone @/CHEMICALSrc$ , and resulting changes in semen parameters .	1 9 5 5 9 8 8 5 1 11 9 16 16 16|13 16 16|13 11 16 16 16 16 16 9 9 22 26 26 23 9	Negative_Correlation
11792932	CHEMICAL	GENE	T7	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ anastrozole @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of @CHEMICALSrc$ anastrozole @/CHEMICALSrc$ , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios .	2 2 4 2 6 4|5 4 4|5 6 14 11 14 10|14 14 10|14 6 6 18 18 4 18 18 18 24 24 21 29 29 29 29 4 2	Negative_Correlation
11792932	CHEMICAL	GENE	T17	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] CONCLUSIONS : Men who are infertile with a low serum @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratio can be treated with an @GENETgt$ aromatase @/GENETgt$ inhibitor .	1 1 16 6 6 3 13 13 13 13 10|13 13 10|13 6 16 16 1 21 21 17|21 21 17|21 16 1	None-BC7
11792932	CHEMICAL	GENE	T18	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] CONCLUSIONS : Men who are infertile with a low serum @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratio can be treated with an @GENETgt$ aromatase @/GENETgt$ inhibitor .	1 1 16 6 6 3 13 13 13 13 10|13 13 10|13 6 16 16 1 21 21 17|21 21 17|21 16 1	None-BC7
11972613	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of CysLT antagonists ( pranlukast and @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 9 9 6 11 9 11 11|12 11 11|12 11 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T12	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ cysteinyl leukotriene @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @CHEMICALSrc$ cysteinyl leukotriene @/CHEMICALSrc$ ( CysLT ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 8|9|21 8|9|21 9|21 8|9|21 15 15 15 21 19 19|14 19 19|14 15 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T1	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] The influence of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists on @GENETgt$ IL-5 @/GENETgt$ activity was assessed .	2 12 6 3|6 6 3|6 2 10 10|6 10 10|6 2 12 12 12	None-BC7
11972613	CHEMICAL	GENE	T15	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ cysteinyl leukotriene (CysLT) receptor @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @GENETgt$ cysteinyl leukotriene ( @/GENETgt$ @CHEMICALSrc$ CysLT ) receptor @/CHEMICALSrc$ ( CysLT1 receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 8|9|21|13 8|9|21|13 8|9|21|13 9|21|13 8|9|21|13 9|21|13 9|21|13 9|21|13 21|13 9|21|13 19 19 13 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T7	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Thus , it is likely that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ indirectly cause antigen-induced eosinophilia through @GENETgt$ IL-5 @/GENETgt$ production .	5 5 5 5 5 10 10|6 10 10|6 10 5 12 10 16 16|12 16 16|12 10 5	None-BC7
11972613	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled ovalbumin ( @GENETgt$ OVA @/GENETgt$ ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and OVA mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 15 7 5|6 5 5|6 7 5 9|5 5 9|5 11 11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T15	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by cysteinyl leukotriene ( @CHEMICALSrc$ CysLT @/CHEMICALSrc$ ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 10 21 15 11|15 15 11|15 15 21 19 19|15 19 19|15 15 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T5	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Increased @GENETgt$ IL-5 @/GENETgt$ activity in the serum was inhibited by both pranlukast and @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ by over 90 % .	4 1|4 4 1|4 9 7 7 4 9 9 12 12 9 12 12 12 12 19 18 19 9 9	Negative_Correlation
11972613	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists ( pranlukast and MCI-826 ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 10 10|7 10 10|7 6 12 10 12 12 12 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] At the fifth challenge , the effects of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists and an @GENETgt$ anti-IL-5 @/GENETgt$ antibody ( TRFK-5 ) on the occurrence of LAR , and blood and lung eosinophilia , which appeared at 5 h after challenge , were examined .	4 4 4 41 41 7 41 11 8|11 11 8|11 7 11 16 16|12 16 16|12 11 18 16 18 22 22 7 24 22 24 24 24 27 27 22 7 33 7 36 36 33 38 36 7 41 41 41	None-BC7
11972613	CHEMICAL	GENE	T8	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by cysteinyl leukotriene ( CysLT ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 20 10 20 14 14 14 20 18 18|15 18 18|15 14 18 7 23 23 20 25 23 25 25 7 7 37 37|29 37 37|29 37 35 37 35 29 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T13	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ ovalbumin @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled @GENETgt$ ovalbumin @/GENETgt$ ( OVA ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and OVA mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 4|15 15 4|15 8 5 8 5 9|5 5 9|5 11 11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T6	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] CONCLUSIONS : @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ produced after antigen provocation sequentially induced @GENETgt$ IL-5 @/GENETgt$ production from some immune component cells via CysLT1 receptor activation .	1 1 2|10 10 2|10 3 8 8 5 10 1 9|13 13 9|13 10 18 18 18 18 13 22 22 22 10 1	None-BC7
11972613	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Increased @GENETgt$ IL-5 @/GENETgt$ activity in the serum was inhibited by both @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and MCI-826 by over 90 % .	4 1|4 4 1|4 9 7 7 4 9 9 12 12 9|10 9 9|10 12 12 19 18 19 9 9	Negative_Correlation
11972613	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled ovalbumin ( OVA ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 15 7 5 7 5 9|5 5 9|5 10 10|11 10 10|11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T8	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ cysteinyl leukotriene (CysLT) receptor @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @GENETgt$ cysteinyl leukotriene ( CysLT ) receptor @/GENETgt$ ( CysLT1 receptor ) antagonists in several species including humans and guinea-pigs , suggesting that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 20 8|9|20 8|9|20 8|9|20 8|9|20 8|9|20 8|9|20 9|20 8|9|20 18 18 9 18 7 23 23 20 25 23 25 25 7 7 37 24|37 37 24|37 37 35 37 35 29 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of CysLT antagonists ( @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and MCI-826 ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 9 9 6 11 9|10 9 9|10 11 11 11 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T6	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] CONCLUSIONS : @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ produced after antigen provocation sequentially induced IL-5 production from some immune component cells via @GENETgt$ CysLT1 @/GENETgt$ receptor activation .	1 1 2|10 10 2|10 3 8 8 5 10 1 12 10 17 17 17 17 12 22 17|22 22 17|22 22 10 1	Positive_Correlation
11972613	CHEMICAL	GENE	T16	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Cysteinyl leukotriene @/CHEMICALSrc$ and @GENETgt$ interleukin-5 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Cysteinyl leukotriene-dependent @/CHEMICALSrc$ @GENETgt$ interleukin-5 @/GENETgt$ production leading to eosinophilia during late asthmatic response in guinea-pigs .	0|1 0|1 1 0|1 1|6 6 1|6 1 6 9 7 13 13 13 7 15 13 1	None-BC7
12123767	CHEMICAL	GENE	T3	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] In addition to this pronounced loss of function , @GENETgt$ M1766L @/GENETgt$ also showed a 10-fold increase in the persistent late @CHEMICALSrc$ sodium @/CHEMICALSrc$ current .	2 13 6 6 6 2 8 6 13 9|13 13 9|13 13 13 16 16 13 23 23 23 23 19|23 23 19|23 16 13	None-BC7
12123767	CHEMICAL	GENE	T4	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] CONCLUSIONS : These findings suggest that @GENETgt$ M1766L-SCN5A @/GENETgt$ channel dysfunction may contribute to the basis of lethal arrhythmias , displays an overlapping electrophysiological phenotype , and represents the first @CHEMICALSrc$ sodium @/CHEMICALSrc$ channelopathy rescued by drug .	1 1 4 5 1 12 10|6 10 10|6 10 12 12 5 15 15 12 18 18 15 12 12 24 24 24 20 12 12 12 32 32 32|28 32 32|28 27 32 35 33 1	None-BC7
12123767	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] A novel @GENETgt$ SCN5A @/GENETgt$ arrhythmia mutation , M1766L , with expression defect rescued by @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ .	6 6 2|6 6 2|6 6 6 6 6 6 12 12 6 12 15 13 13 13 6	None-BC7
12123767	CHEMICAL	GENE	T1	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] RESULTS : The @GENETgt$ M1766L @/GENETgt$ mutation caused a significant decrease in the @CHEMICALSrc$ sodium @/CHEMICALSrc$ channel expression .	1 1 6 3|6 6 3|6 7 1 10 10 7 16 16 11|15 15 11|15 16 10 1	None-BC7
12123767	CHEMICAL	GENE	T9	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] A novel SCN5A arrhythmia mutation , @GENETgt$ M1766L @/GENETgt$ , with expression defect rescued by @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ .	5 5 5 5 5 5 5|6 5 5|6 5 12 12 5 12 15 13 13 13 5	None-BC7
12123767	CHEMICAL	GENE	T4	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] CONCLUSIONS : These findings suggest that @GENETgt$ M1766L-SCN5A @/GENETgt$ channel dysfunction may contribute to the basis of lethal arrhythmias , displays an overlapping electrophysiological phenotype , and represents the first @CHEMICALSrc$ sodium @/CHEMICALSrc$ channelopathy rescued by drug .	1 1 4 5 1 12 10|6 10 10|6 10 12 12 5 15 15 12 18 18 15 12 12 24 24 24 20 12 12 12 32 32 32|28 32 32|28 27 32 35 33 1	None-BC7
12123767	CHEMICAL	GENE	T5	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] OBJECTIVE : Mutations in the cardiac @CHEMICALSrc$ sodium @/CHEMICALSrc$ channel gene , @GENETgt$ SCN5A @/GENETgt$ , cause congenital long QT syndrome ( LQT3 ) , Brugada syndrome , idiopathic ventricular fibrillation , and conduction disease by distinct cellular and clinical electrophysiological phenotypes .	1 1 15 10 10 10 10|6 10 10|6 10 3 10 10 10 10 3 1 19 19 19 15 21 19 21 19 25 19 19 29 29 19 19 19 33 19 36 36 15 36 36 36 36 1	None-BC7
12719755	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ Angiotensin II @/CHEMICALSrc$ and @GENETgt$ angiotensin AT1 receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Angiotensin II @/CHEMICALSrc$ acting on @GENETgt$ angiotensin AT1 receptors @/GENETgt$ at the central nervous system appears to have an important role in these modulatory processes .	0|1|15 0|1|15 1|15 0|1|15 1 6 3|4|6 3|4|6 3|4|6 4|6 3|4|6 14 14 14 14 4 15 17 15 20 20 17 24 24 24 17 15	None-BC7
12719755	CHEMICAL	GENE	T4	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ pancuronium bromide @/CHEMICALSrc$ and @GENETgt$ AT1 receptor @/GENETgt$ ? [SEP] We investigated the effect of @GENETgt$ AT1 receptor @/GENETgt$ blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent @CHEMICALSrc$ pancuronium bromide @/CHEMICALSrc$ .	2 2 4 2 9 9|5 9|5 9 9|5 4 12 12 9 15 15 4 17 15 19 17 22 22 17 22 29 29 27 29 29 26|29|23 26|29|23 29|23 26|29|23 2	Negative_Correlation
12719755	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ angiotensin @/CHEMICALSrc$ and @GENETgt$ Angiotensin II @/GENETgt$ ? [SEP] @GENETgt$ Angiotensin II @/GENETgt$ acting on @CHEMICALSrc$ angiotensin @/CHEMICALSrc$ AT1 receptors at the central nervous system appears to have an important role in these modulatory processes .	0|1|15 0|1|15 1|15 0|1|15 1 9 9|3 9 9|3 9 4 14 14 14 14 4 15 17 15 20 20 17 24 24 24 17 15	None-BC7
12719755	CHEMICAL	GENE	T6	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ losartan @/CHEMICALSrc$ and @GENETgt$ Angiotensin AT1 receptor @/GENETgt$ ? [SEP] @GENETgt$ Angiotensin AT1 receptor @/GENETgt$ antagonist @CHEMICALSrc$ losartan @/CHEMICALSrc$ and the defence reaction in the anaesthetised rat .	0|6 0|6 0|6 6 0|6 6 2|6 6 2|6 6 11 11 6 15 15 15 11 6	Negative_Correlation
15723099	CHEMICAL	GENE	T30	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 41|46 46 41|46 46 41 11	None-BC7
15723099	CHEMICAL	GENE	T3	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10 18 10 10 38 25 25 38 27 25 27 26|27 27 26|27 38 38 36 33 36 38 36 21 42 41 42 38 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T1	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10|18|15 10|18|15 10|18 10|18|15 10 10 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 10	Negative_Correlation
15723099	CHEMICAL	GENE	T9	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptors @/GENETgt$ ? [SEP] Dextromethorphan and @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ are high-affinity ligands at @GENETgt$ sigma1 receptors @/GENETgt$ .	7 1 1|2 1 1|2 7 7 7 9 9|7 9|7 9|7 9|7 7	Association
15723099	CHEMICAL	GENE	T3	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24 26 26|27 26 26|27 37 37 35 32 35 37 35 20 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T2	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24|25 24 24|25 26 26 37 37 35 32 35 37 35 20 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T25	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ activator protein (AP)-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression , @GENETgt$ activator protein (AP)-1 @/GENETgt$ DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 11 11 8 11 18|11 18|11 18|11 18 18|11 18 11 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	Negative_Correlation
15723099	CHEMICAL	GENE	T31	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T25	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ c-fos @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	Negative_Correlation
15723099	CHEMICAL	GENE	T2	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24|25 24 24|25 26 26 37 37 35 32 35 37 35 20 41 40 41 37 46 41|46 46 41|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T26	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ activator protein (AP)-1 @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in c-fos/c-jun expression , @GENETgt$ activator protein (AP)-1 @/GENETgt$ DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 11 11 8 11 18|11 18|11 18|11 18 18|11 18 11 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	Positive_Correlation
15723099	CHEMICAL	GENE	T31	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 41|46 46 41|46 46 41 11	None-BC7
15723099	CHEMICAL	GENE	T34	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ analog dimemorfan attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of dextromethorphan .	5 1|5 5 1|5 5 6 6 8 6 13 8|13 8|13 13 8|13 6 6 6 18 18 15 20 18 6	Positive_Correlation
15723099	CHEMICAL	GENE	T2	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10 18 10 10 38 25 25 38 27 24|25 25 24|25 27 27 38 38 36 33 36 38 36 21 42 41 42 38 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T31	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 19 19 19 19|13 19|13 19 19|13 19 11 19 11 11 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T25	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ c-jun @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	Negative_Correlation
15723099	CHEMICAL	GENE	T30	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 19 19 19 19|13 19|13 19 19|13 19 11 19 11 11 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T32	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ .	4 4 4 5 5 7 5 12 8|12 8|12 12 8|12 5 5 5 17 17 14 19 16|17 17 16|17 5	None-BC7
15723099	CHEMICAL	GENE	T33	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The dextromethorphan analog @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of dextromethorphan .	4 4 4 3|6 6 3|6 6 8 6 13 8|13 8|13 13 8|13 6 6 6 18 18 15 20 18 6	Positive_Correlation
15723099	CHEMICAL	GENE	T1	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 16|17|10 16|17|10 17|10 16|17|10 10 10 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|36|39 42|36|39 42|39 42|36|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T1	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 16|17|10 16|17|10 17|10 16|17|10 10 10 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 40|46 46 40|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T30	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T3	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24 26 26|27 26 26|27 37 37 35 32 35 37 35 20 41 40 41 37 46 41|46 46 41|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T4	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ Dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dextromethorphan @/CHEMICALSrc$ and dimemorfan are high-affinity ligands at @GENETgt$ sigma1 receptors @/GENETgt$ .	0|7 7 0|7 1 1 7 7 7 9 9|7 9|7 9|7 9|7 7	Association
15723099	CHEMICAL	GENE	T26	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ c-jun @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	Positive_Correlation
15723099	CHEMICAL	GENE	T26	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ c-fos @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	Positive_Correlation
23572389	CHEMICAL	GENE	T1	T4	True	0	What is [Drugprot] between @CHEMICALSrc$ calcium @/CHEMICALSrc$ and @GENETgt$ E-cadherin @/GENETgt$ ? [SEP] @GENETgt$ E-cadherin @/GENETgt$ is a transmembrane glycoprotein that mediates @CHEMICALSrc$ calcium-dependent @/CHEMICALSrc$ interactions between adjacent epithelial cells .	0|6 6 0|6 6 6 6 6 8 6 11|7 11 11|7 8 15 15 15 11 6	None-BC7
23314054	CHEMICAL	GENE	T4	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] Fragment-based design , synthesis , and biological evaluation of @CHEMICALSrc$ N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide @/CHEMICALSrc$ derivatives as novel @GENETgt$ Mcl-1 @/GENETgt$ inhibitors .	2 2 2 2 4 4 8 4 12 9|12 12 9|12 4 17 17 17|13 17 17|13 2 2	Negative_Correlation
23314054	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] A novel potent compound , @CHEMICALSrc$ N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide @/CHEMICALSrc$ ( 12c ) , which binds @GENETgt$ Mcl-1 @/GENETgt$ with an IC(50 ) value of 54 nM was obtained .	4 4 4 26 4 4|5|6 4|5|6 4|6 4|5|6 10 6 10 4 14 4 12|14 14 12|14 21 21 21 21 14 24 24 21 26 26 26	Association
23314054	CHEMICAL	GENE	T3	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ 3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] We have previously reported a nanomolar inhibitor of antiapoptotic @GENETgt$ Mcl-1 @/GENETgt$ protein , @CHEMICALSrc$ 3-thiomorpholin-8-oxo-8H-acenaphtho [ 1,2-b ] pyrrole-9-carbonitrile @/CHEMICALSrc$ ( S1 ) .	4 4 4 4 7 7 4 12 12 9|12 12 9|12 7 12 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 21 12 21 4	Negative_Correlation
1666997	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT1A @/GENETgt$ ? [SEP] By contrast , neither @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ nor amitriptyline can be considered as possible ligands of @GENETgt$ 5-HT1A @/GENETgt$ and 5-HT1B receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11|4 11 11|4 5 5 11 11 11 14 14 11 16 14 14 14 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T3	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ ? [SEP] Finally we explored whether acute and/or chronic administration of @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ or amitriptyline affected the levels of opioid peptides and the @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS )	3 3 3 14 14 5 5 5 10 8|9 8 8|9 10 10 3 16 14 19 19 16 19 22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|21|22 19|20|21|22 32 32 22 35 35 32 35 39 39 35 16 43 43 40 3	None-BC7
1666997	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT1B @/GENETgt$ ? [SEP] By contrast , neither @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ nor amitriptyline can be considered as possible ligands of 5-HT1A and @GENETgt$ 5-HT1B @/GENETgt$ receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11|4 11 11|4 5 5 11 11 11 14 14 11 16 14 16 16 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Interestingly , @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ binds with a good affinity ( IC50 = 0.30 microM ) to @GENETgt$ 5-HT3 @/GENETgt$ receptors labelled by [3H]zacopride in cortical membranes .	5 5 2|5 5 2|5 5 9 9 9 5 11 9 11 14 12 11 19 19|15 19 19|15 5 19 22 20 25 25 20 5	Association
1666997	CHEMICAL	GENE	T15	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the @GENETgt$ 5-HT3-dependent @/GENETgt$ Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on 5-HT3 receptors .	2 9 2 8 8|4 8 8|4 8 3 9 13 13 13 9 15 13 19 19 19 13 21 19 21 24 22 24 21 21 13 34 34|28 34 34|28 34 34 13 37 37 34 9	None-BC7
1666997	CHEMICAL	GENE	T4	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ ? [SEP] Finally we explored whether acute and/or chronic administration of amoxapine or @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ affected the levels of opioid peptides and the @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS )	3 3 3 14 14 5 5 5 10 8 10 10|11 10 10|11 3 16 14 19 19 16 19 22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|21|22 19|20|21|22 32 32 22 35 35 32 35 39 39 35 16 43 43 40 3	None-BC7
1666997	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and amitriptyline interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by [3H]ketanserin in cortical membranes .	4 1 4 5 5 12 8 12|7 12 12|7 8 8 5 16 16 16 12 20 16|20 20 16|20 16 20 23 21 26 26 21 5	Association
1666997	CHEMICAL	GENE	T6	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both amoxapine and @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by [3H]ketanserin in cortical membranes .	4 1 4 5 5 12 8 12 8 8|9 8 8|9 5 16 16 16 12 20 16|20 20 16|20 16 20 23 21 26 26 21 5	Association
1666997	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]zacopride @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Interestingly , amoxapine binds with a good affinity ( IC50 = 0.30 microM ) to @GENETgt$ 5-HT3 @/GENETgt$ receptors labelled by @CHEMICALSrc$ [3H]zacopride @/CHEMICALSrc$ in cortical membranes .	4 4 4 4 8 8 8 4 10 8 10 13 11 10 18 18|15 18 18|15 4 18 21 19 19 19 25 25 19 4	Association
1666997	CHEMICAL	GENE	T14	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the @GENETgt$ 5-HT3-dependent @/GENETgt$ Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on 5-HT3 receptors .	2 9 2 8 8|4 8 8|4 8 3 9 14 9|14 14 9|14 14 9 16 14 20 20 20 14 22 20 22 25 23 25 22 22 14 34 34 34 34 14 37 37 34 9	None-BC7
1666997	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a @GENETgt$ 5-HT3 @/GENETgt$ antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on 5-HT3 receptors .	2 8 2 7 7 7 3 8 13 9|13 13 9|13 13 8 15 13 20 20 16|20 20 16|20 13 22 20 22 25 23 25 22 22 13 34 34 34 34 13 37 37 34 8	Negative_Correlation
1666997	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]ketanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by @CHEMICALSrc$ [3H]ketanserin @/CHEMICALSrc$ in cortical membranes .	4 1 4 5 5 11 8 11 8 8 5 15 15 15 11 19 16|19 19 16|19 15 19 22 20 20 20 26 26 20 5	Association
1666997	CHEMICAL	GENE	T14	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on @GENETgt$ 5-HT3 @/GENETgt$ receptors .	2 8 2 7 7 7 3 8 13 9|13 13 9|13 13 8 15 13 19 19 19 13 21 19 21 24 22 24 21 21 13 33 33 33 33 13 37 33|37 37 33|37 33 8	None-BC7
1666997	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT1B @/GENETgt$ ? [SEP] By contrast , neither amoxapine nor @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ can be considered as possible ligands of 5-HT1A and @GENETgt$ 5-HT1B @/GENETgt$ receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11 5 5|6 5 5|6 11 11 11 14 14 11 16 14 16 16 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T15	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a @GENETgt$ 5-HT3 @/GENETgt$ antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on 5-HT3 receptors .	2 8 2 7 7 7 3 8 12 12 12 8 14 12 19 19 16|19 19 16|19 12 21 19 21 24 22 24 21 21 12 34 34|28 34 34|28 34 34 12 37 37 34 8	None-BC7
1666997	CHEMICAL	GENE	T2	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT receptors @/GENETgt$ ? [SEP] The second part of this study consisted of looking for possible changes in central @GENETgt$ 5-HT receptors @/GENETgt$ 24 h after either a single or a repeated ( for 14 days ) treatment with amoxapine ( 10 mg/kg i.p . each day ) or @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ ( 10 mg/kg i.p . ) .	3 3 7 6 6 3 7 9 7 12 12 9 15 15 12|14|15 12|14|15 12|15 12|14|15 19 9 23 23 23 9 23 26 23 30 30 30 23 30 23 34 32 37 37 38 23 7 41 41 41 41 41 41 41 48 48 49 44 44 41 41	None-BC7
1666997	CHEMICAL	GENE	T15	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on @GENETgt$ 5-HT3 @/GENETgt$ receptors .	2 8 2 7 7 7 3 8 12 12 12 8 14 12 18 18 18 12 20 18 20 23 21 23 20 20 12 33 33|28 33 33|28 33 33 12 37 33|37 37 33|37 33 8	None-BC7
1666997	CHEMICAL	GENE	T1	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT receptors @/GENETgt$ ? [SEP] The second part of this study consisted of looking for possible changes in central @GENETgt$ 5-HT receptors @/GENETgt$ 24 h after either a single or a repeated ( for 14 days ) treatment with @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ ( 10 mg/kg i.p . each day ) or amitriptyline ( 10 mg/kg i.p . ) .	3 3 7 6 6 3 7 9 7 12 12 9 15 15 12|14|15 12|14|15 12|15 12|14|15 19 9 23 23 23 9 23 26 23 30 30 30 23 30 23 34 32|31 32 32|31 38 38 39 23 7 42 42 42 42 42 48 48 49 45 45 42 42	None-BC7
1666997	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT1A @/GENETgt$ ? [SEP] By contrast , neither amoxapine nor @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ can be considered as possible ligands of @GENETgt$ 5-HT1A @/GENETgt$ and 5-HT1B receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11 5 5|6 5 5|6 11 11 11 14 14 11 16 14 14 14 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
23402628	CHEMICAL	GENE	T8	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ thiol @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of -tertiary amine self-assembled @CHEMICALSrc$ thiol @/CHEMICALSrc$ monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 9 9 6 9 9|6 9 9|6 2 13 13 13 2 15 15 17 15 19 17 22 22 19 21|22 22 21|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ -tertiary amine @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of @CHEMICALSrc$ -tertiary amine @/CHEMICALSrc$ self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 9 9|3|7 9|3|7 9|7 9|3|7 9 9 2 13 13 13 2 15 15 17 15 19 17 22 22 19 20|22 22 20|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Oxidation with @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ was similarly assessed , and adhesion of lysozyme and @GENETgt$ fibrinogen @/GENETgt$ from phosphate buffered saline was then assayed by QCM and imaged by AFM .	8 3 1|2|3 1|2|3 1|3 1|2|3 8 8 8 8 8 23 13 11 13 12|13 13 12|13 20 19 20 11 23 23 8 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T11	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Tertiary amine @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] @CHEMICALSrc$ Tertiary amine-functionalized @/CHEMICALSrc$ sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas tertiary amine N-oxides and triethylene glycol-terminated monolayers are consistent with small protein aggregates .	0|4 0|4 4 0|4 5 5 5 9 9 6 6 6 5 5 15 15 21 15 18 19 21 21 5 25 25 25 21 5	None-BC7
23402628	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Oxidation with @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ was similarly assessed , and adhesion of @GENETgt$ lysozyme @/GENETgt$ and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM .	8 3 1|2|3 1|2|3 1|3 1|2|3 8 8 8 8 8 23 13 10|11 11 10|11 13 13 20 19 20 11 23 23 8 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ -tertiary amine @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of @CHEMICALSrc$ -tertiary amine @/CHEMICALSrc$ self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 9 9|3|7 9|3|7 9|7 9|3|7 9 9 2 13 13 13 2 15 15 17 15 19 17 22 22 19 22 23 22|23 23 22|23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T10	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphate @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Oxidation with hydrogen peroxide was similarly assessed , and adhesion of @GENETgt$ lysozyme @/GENETgt$ and fibrinogen from @CHEMICALSrc$ phosphate @/CHEMICALSrc$ buffered saline was then assayed by QCM and imaged by AFM .	7 4 4 1 7 7 7 7 7 23 12 10|11 10 10|11 12 12 20 19|15 19 19|15 20 10 23 23 7 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T8	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ thiol @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of -tertiary amine self-assembled @CHEMICALSrc$ thiol @/CHEMICALSrc$ monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 9 9 6 9 9|6 9 9|6 2 13 13 13 2 15 15 17 15 19 17 22 22 19 22 23 23 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T10	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphate @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Oxidation with hydrogen peroxide was similarly assessed , and adhesion of lysozyme and @GENETgt$ fibrinogen @/GENETgt$ from @CHEMICALSrc$ phosphate @/CHEMICALSrc$ buffered saline was then assayed by QCM and imaged by AFM .	7 4 4 1 7 7 7 7 7 23 12 10 12 12|13 12 12|13 20 19|15 19 19|15 20 10 23 23 7 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T12	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of -tertiary amine self-assembled thiol monolayers to @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 8 8 6 8 8 2 10 9|10|2 9|10|2 9|10|2 10|2 9|10|2 15 15 17 15 19 17 22 22 19 19|22 22 19|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T14	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ triethylene glycol @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Tertiary amine-functionalized sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas tertiary amine N-oxides and @CHEMICALSrc$ triethylene glycol-terminated @/CHEMICALSrc$ monolayers are consistent with small protein aggregates .	3 3 4 4 4 8 8 5|7 5 5|7 4 4 14 14 21 14 16|19|14 16|19|14 16|19 16|19|14 21 21 4 25 25 25 21 4	None-BC7
23402628	CHEMICAL	GENE	T13	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Tertiary amine-functionalized sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and triethylene glycol-terminated monolayers are consistent with small protein aggregates .	3 3 4 4 4 8 8 5|7 5 5|7 4 4 10|12|21 10|12|21 10|12|21 12|21 10|12|21 12 18 19 21 21 4 25 25 25 21 4	None-BC7
23402628	CHEMICAL	GENE	T12	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of -tertiary amine self-assembled thiol monolayers to @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 8 8 6 8 8 2 10 9|10|2 9|10|2 9|10|2 10|2 9|10|2 15 15 17 15 19 17 22 22 19 22 23 21|23 23 21|23 28 19 15	None-BC7
10640321	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 18|19 19 18|19 19 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	Positive_Correlation
10640321	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 19 19 8 8 26 8 28 26 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T18	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] In this study , the activity of the @GENETgt$ delta-opioid receptor @/GENETgt$ subtype-selective agonist , @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , was investigated in a guinea pig model of citric acid-induced cough .	3 3 20 20 6 20 13 13 8|12|13 8|12|13 12|13 8|12|13 13 6 13 12|13|15 12|13|15 13|15 12|13|15 6 20 20 25 25 25 25 20 29 29 29 25 20	Positive_Correlation
10640321	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18|19 18 18|19 18 9 9 9|25|23 9|25|23 9|25 9|25|23 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T7	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9|10|11 9|10|11 9|11 9|10|11 11 9 16|9|13 16|9|13 16|9 16|9|13 20 16 20 20 20 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T6	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] These studies provide compelling evidence that the antitussive effects of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ in this guinea pig cough model are mediated by agonist activity at the @GENETgt$ delta-opioid receptor @/GENETgt$ .	2 3 3 5 3 21 9 9 21 11 9|10|11 9|10|11 9|11 9|10|11 19 19 19 19 19 9 21 5 24 24 21 27 27 24|27 24|27 24|27 24|27 3	Positive_Correlation
10640321	CHEMICAL	GENE	T16	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-receptor @/GENETgt$ ? [SEP] The @GENETgt$ delta-receptor @/GENETgt$ antagonist , SB 244525 ( 10 mg/kg , i.p . ) , inhibited the antitussive effect of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	4 1|4 4 1|4 16 4 4 6 10 10 6 10 10 10 10 16 16 19 19 16 21 19|21 19|21 19|21 19|21 26 26 21 26 26 26 26 16	Positive_Correlation
10640321	CHEMICAL	GENE	T19	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 10 10 10 10 5 5 13 5 13 13 13 13 5 18|5 5 18|5 23 23 19 23 26 23 26 26 26 23 19 33 5 35 33 38 38 35 40 40|38 40|38 40|38 40|38 40|38 40 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T11	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 19 19 9 9 26 9 28 26 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] In this study , the activity of the @GENETgt$ delta-opioid receptor @/GENETgt$ subtype-selective agonist , SB 227122 , was investigated in a guinea pig model of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough .	3 3 19 19 6 19 13 13 8|12|13 8|12|13 12|13 8|12|13 13 6 13 13 15 6 19 19 24 24 24 24 19 29 29|23 29|23 29 29|23 24 19	None-BC7
10640321	CHEMICAL	GENE	T17	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11|6 11 11|6 11 11 5 5 14 5 14 14 14 14 5 5 23 23 20 23 26 23 26 26 26 23 20 33 5 35 33 38 38 35 40 40|38 40|38 40|38 40|38 40|38 40 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T1	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 10 10 10 10 5 5 13 5 13 13 13 13 5 5 22 22 19 22 25 22 25 25 25 22 19 32 5 34 32 37 37 34 39 37|38|39 37|38|39 37|38|39 37|39 37|38|39 39 5 5 5 49 49 49 53 53 53 49 55 51|53|55 51|53|55 53|55 51|53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T11	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18 18 9 9 24|9|23 24|9|23 24|9 24|9|23 28 24 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T14	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 17 6 6 11 11 8 11 11 11 11 6 17 20 20 17 22 20 22 24|21|22 24|21|22 24|22 24|21|22 17 17 38 32 32 38 35 35 32 38 38 28 17	Positive_Correlation
10640321	CHEMICAL	GENE	T12	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ naloxone @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , @CHEMICALSrc$ naloxone @/CHEMICALSrc$ ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or SB 227122 , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 17 5 5|6 5 5|6 11 11 7 11 11 11 11 5 17 20 20 17 22 20 22 22 24 17 17 36 31 31 36 34 34 31 36 34|27|36 34|27|36 27|36 34|27|36 17	None-BC7
10640321	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 18|19 19 18|19 19 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 16 5 5 10 10 7 10 10 10 10 5 16 19 19 16 21 19 21 21|22|23 21|22|23 21|23 21|22|23 16 16 36 31 31 36 34 34 31 36 33|27|36 33|27|36 27|36 33|27|36 16	Positive_Correlation
10640321	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8|9|12 8|9|12 8|12 8|9|12 12 8 18 8 20 18 20 20 20 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	Positive_Correlation
10640321	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18 18 9 9 24|9|23 24|9|23 24|9 24|9|23 28 24|25|28 24|25|28 24|28 24|25|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	Positive_Correlation
10640321	CHEMICAL	GENE	T8	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 16|15 15 16|15 19 19 19 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	Positive_Correlation
10640321	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of @CHEMICALSrc$ codeine @/CHEMICALSrc$ or SB 227122 , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 17 6 6 11 11 8 11 11 11 11 6 17 20 20 17 22 19|20 20 19|20 22 22 25 17 17 38 32 32 38 35 35 32 38 38 28 17	Positive_Correlation
10640321	CHEMICAL	GENE	T8	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16|17 16 16|17 18 18 18 9 9 9|25|23 9|25|23 9|25 9|25|23 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 19 19 8 8 26 8 28 25|26|28 25|26|28 26|28 25|26|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T15	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 244525 @/CHEMICALSrc$ and @GENETgt$ delta-receptor @/GENETgt$ ? [SEP] The @GENETgt$ delta-receptor @/GENETgt$ antagonist , @CHEMICALSrc$ SB 244525 @/CHEMICALSrc$ ( 10 mg/kg , i.p . ) , inhibited the antitussive effect of SB 227122 ( 20 mg/kg , i.p . ) .	4 1|4 4 1|4 17 4 4|6 4|6 4|6 4|6 11 11 6 11 11 11 11 17 17 20 20 17 22 20 22 26 26 22 26 26 26 26 17	Negative_Correlation
10640321	CHEMICAL	GENE	T19	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 10 10 10 10 5 5 13 5 13 13 13 13 5 18|5 5 18|5 24 24|20 24 24|20 19 24 27 24 27 27 27 24 19 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	Negative_Correlation
10640321	CHEMICAL	GENE	T3	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist rimcazole ( 3 mg/kg , i.p . ) inhibited the antitussive effect of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of SB 227122 .	5 1|5 5 1|5 5 13 8 8 5 8 8 8 8 13 16 16 13 18 16 16 16 22 22 18 22 22 22 22 18 30 30 18 18 33 18 18 36 34 36 13	Positive_Correlation
10640321	CHEMICAL	GENE	T2	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ rimcazole @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist @CHEMICALSrc$ rimcazole @/CHEMICALSrc$ ( 3 mg/kg , i.p . ) inhibited the antitussive effect of dextromethorphan ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of SB 227122 .	5 1|5 5 1|5 5 3|14 14 3|14 9 9 5 9 9 9 9 14 17 17 14 19 17 22 22 19 22 22 22 22 19 30 30 19 19 33 19 19 36 34 36 14	Negative_Correlation
10640321	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 19 19 9 9 26 9 28 25|26|28 25|26|28 26|28 25|26|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T17	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11|6 11 11|6 11 11 5 5 14 5 14 14 14 14 5 5 24 24|20 24 24|20 20 24 27 24 27 27 27 24 20 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T1	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 10 10 10 10 5 5 13 5 13 13 13 13 5 5 23 20|23 23 20|23 19 23 26 23 26 26 26 23 19 33 5 35 33 38 38 35 40 38 40 40 40 5 5 5 49 49 49 53 53 53 49 55 53|55 53|55 53|55 53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T12	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ naloxone @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , @CHEMICALSrc$ naloxone @/CHEMICALSrc$ ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or SB 227122 , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 18 6 5|6 6 5|6 12 12 8 12 12 12 12 6 18 21 21 18 23 21 23 23 25 18 18 38 32 32 38 35 35 32 38 38 28 18	Negative_Correlation
10640321	CHEMICAL	GENE	T4	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist rimcazole ( 3 mg/kg , i.p . ) inhibited the antitussive effect of dextromethorphan ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ .	5 1|5 5 1|5 5 13 8 8 5 8 8 8 8 13 16 16 13 18 16 21 21 18 21 21 21 21 18 29 29 18 18 32 18 18 35 33|35 33|35 33|35 33|35 13	None-BC7
10640321	CHEMICAL	GENE	T19	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11 11 8|11 11 8|11 5 5 14 5 14 14 14 14 5 18|5 5 18|5 24 24 20 24 27 24 27 27 27 24 20 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T17	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 12 12|6 12 12|6 12 8|12 12 8|12 5 5 15 5 15 15 15 15 5 5 24 24 21 24 27 24 27 27 27 24 21 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	Negative_Correlation
10640321	CHEMICAL	GENE	T7	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9|10|11 9|10|11 9|11 9|10|11 11 9 17 9 19 17 19 19 19 9 9 9|22|25 9|22|25 9|25 9|22|25 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T1	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 11 11 11 8|11 11 8|11 5 5 14 5 14 14 14 14 5 5 23 23 20 23 26 23 26 26 26 23 20 33 5 35 33 38 38 35 40 38 40 40 40 5 5 5 49 49 49 53 53 53 49 55 53|55 53|55 53|55 53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 16|17 17 16|17 19 19 19 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T13	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of @CHEMICALSrc$ codeine @/CHEMICALSrc$ or SB 227122 , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 16 5 5 10 10 7 10 10 10 10 5 16 19 19 16 21 19|20 19 19|20 21 21 24 16 16 36 31 31 36 34 34 31 36 34|27|36 34|27|36 27|36 34|27|36 16	Positive_Correlation
23504356	CHEMICAL	GENE	T1	T3	True	0	What is [Drugprot] between @CHEMICALSrc$ fenfluramine @/CHEMICALSrc$ and @GENETgt$ secretin @/GENETgt$ ? [SEP] While studies of @CHEMICALSrc$ fenfluramine @/CHEMICALSrc$ , @GENETgt$ secretin @/GENETgt$ , opiates , and mood stabilizers generally find no effect , mixed results suggest more research is needed on antidepressants and atypical antipsychotics .	16 16 4 2|3 2 2|3 4 4|5 4 4|5 7 7 10 4 14 4 16 22 18 16 22 21 22 22 24 26 26 22 28 26 28 31 28 22	None-BC7
23506741	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-18 @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF- , IL-1 , @GENETgt$ IL-18 @/GENETgt$ , IL-17A and IFN- , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 18|15 15 18|15 15 15 22 22 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ cytokines @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory @GENETgt$ cytokines @/GENETgt$ in colon , including TNF- , IL-1 , IL-18 , IL-17A and IFN- , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 9|6 6 9|6 13 10 13 16 13 16 16 16 16 16 16 22 22 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-17A @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF- , IL-1 , IL-18 , @GENETgt$ IL-17A @/GENETgt$ and IFN- , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 15 15 20|15 15 20|15 21 21 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ TNF- @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including @GENETgt$ TNF- @/GENETgt$ , IL-1 , IL-18 , IL-17A and IFN- , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12|14 12 12|14 15 15 15 15 15 15 22 22 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T1	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a @/CHEMICALSrc$ and @GENETgt$ caspase-1 @/GENETgt$ ? [SEP] Furthermore , a decreased CD11c(+ ) macrophage infiltration in colons and inactivation of @GENETgt$ caspase-1 @/GENETgt$ in peritoneal macrophages were detected in @CHEMICALSrc$ Fc11a-2-treated @/CHEMICALSrc$ mice .	20 20 8 8 8 8 8 20 10 8 10 10 14 12|13 12 12|13 18 18 12 20 20 24 24|20 24 24|20 20 20	Negative_Correlation
23506741	CHEMICAL	GENE	T5	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ , for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 21 21 13 27 27 11 34 34 34 32 34 34 27 36 27 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-1 @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF- , @GENETgt$ IL-1 @/GENETgt$ , IL-18 , IL-17A and IFN- , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 16|15 15 16|15 15 15 15 15 22 22 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T11	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ benzo[d]imidazole @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] A novel @CHEMICALSrc$ benzo[d]imidazole @/CHEMICALSrc$ derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	5 5 2|5 5 2|5 6 6 8 6 15 12 12 15 15 15 8 17 6 21 17|21 21 17|21 17 6	Negative_Correlation
23506741	CHEMICAL	GENE	T6	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran @CHEMICALSrc$ sulfate @/CHEMICALSrc$ sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 13 26 26 11 34 34 34|28 34 34|28 32 34 34 26 36 26 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T9	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IFN- @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF- , IL-1 , IL-18 , IL-17A and @GENETgt$ IFN- @/GENETgt$ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 15 15 15 21 21|22 21 21|22 3 28 28 28 30 28 28 28 28	Negative_Correlation
23506741	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of pro-caspase-1 , pro-IL-1 and pro-IL-18 which in turn suppressed the activation of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 17 17 17 17 25 24 25 15 27 25 31 27|31 31 27|31 27 9	Negative_Correlation
23506741	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of @CHEMICALSrc$ 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole @/CHEMICALSrc$ , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11|12 11 11|12 13 20 20 20 20 13 22 20 22 13 27 27 11 34 34 34 32 34 34 27 36 27 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T7	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran sulfate @CHEMICALSrc$ sodium @/CHEMICALSrc$ (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 13 26 26 11 34 34 34 32|29 32 32|29 34 34 26 36 26 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ myeloperoxidase @/GENETgt$ ? [SEP] In addition , the disease activity index , histopathologic scores and @GENETgt$ myeloperoxidase @/GENETgt$ activity were also significantly reduced by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ treatment .	2 18 18 7 7 7 18 7 10 18 10 11|14 14 11|14 10 18 18 18 18 22 18|22 22 18|22 18 18	Negative_Correlation
23506741	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] Taken together , our results demonstrate the ability of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ to inhibit @GENETgt$ NLRP3 @/GENETgt$ inflammasome activation and its potential use in the treatment of inflammatory bowel diseases .	6 1 6 5 6 6 8 6 10 8|9 8 8|9 13 8 17|12 17 17|12 17 13 17 21 21 17 24 24 21 28 28 28 24 6	Negative_Correlation
23506741	CHEMICAL	GENE	T2	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ pro-caspase-1 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of @GENETgt$ pro-caspase-1 @/GENETgt$ , pro-IL-1 and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 15 15 17 17 17 17 26 25 26 15 28 26 31 31 28 9	Negative_Correlation
23506741	CHEMICAL	GENE	T10	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] A novel benzo[d]imidazole derivate prevents the development of dextran sulfate @CHEMICALSrc$ sodium-induced @/CHEMICALSrc$ murine experimental colitis via inhibition of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 5 5 7 5 15 11 11 10|15 15 10|15 15 15 7 17 5 21 17|21 21 17|21 17 5	None-BC7
23506741	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ pro-IL-18 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of pro-caspase-1 , pro-IL-1 and @GENETgt$ pro-IL-18 @/GENETgt$ which in turn suppressed the activation of NLRP3 inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 17 17 17 17|19 17 17|19 26 25 26 15 28 26 31 31 28 9	Negative_Correlation
